Department of Public Health, Research Unit for Epidemiology, Aarhus University, Aarhus, Denmark.
Department of Public Health, Research Unit for Epidemiology, Aarhus University, Aarhus, Denmark; Department of Urology, Aarhus University Hospital, Aarhus, Denmark.
Fertil Steril. 2022 Jul;118(1):136-146. doi: 10.1016/j.fertnstert.2022.03.018. Epub 2022 May 11.
To study whether maternal thyroid disease in pregnancy is associated with pubertal timing in sons and daughters.
Cohort study.
National birth cohort and health registers.
PATIENT(S): A total of 15,763 mothers and children from the Danish National Birth Cohort and its Puberty Cohort.
INTERVENTION(S): Register-based and self-reported information on maternal thyroid diseases during pregnancy (hyperthyroidism, hypothyroidism, benign goiter, or no thyroid disease [reference group]).
MAIN OUTCOME MEASURE(S): The adjusted mean age difference (months) at attaining several self-reported pubertal milestones collected every 6 months using an interval-censored regression and the average difference in age at attaining all pubertal milestones using the Huber-White robust variance estimation (primary outcome).
RESULT(S): Sons of mothers with hyperthyroidism had earlier pubertal development (average difference, -2.9 [95% confidence interval (CI), -5.0 to -0.7] months) than unexposed sons. Maternal hypothyroidism was not associated with pubertal development in sons (average difference, -1.2 [95% CI, -5.1 to 2.7] months). We observed nonstatistically significant indications of earlier pubertal development in sons of mothers with benign goiter (average difference, -1.9 [95% CI, -4.6 to 0.9] months). Maternal thyroid disease was not associated with pubertal development in daughters (average difference (months), hyperthyroidism, -0.8 [95% CI, -2.8 to 1.2]; hypothyroidism, 0.3 [95% CI, -3.1 to 3.8]; and benign goiter, 0.7 [95% CI, -2.0 to 3.4]).
CONCLUSION(S): We found indications of earlier pubertal development in sons of mothers with hyperthyroidism. More research is needed to further investigate the observed sex-specific association.
研究妊娠期间母体甲状腺疾病是否与子女性成熟时间有关。
队列研究。
全国性出生队列和健康登记处。
来自丹麦全国性出生队列及其青春期队列的 15763 名母亲及其子女。
基于登记和自我报告的母亲在怀孕期间的甲状腺疾病信息(甲状腺功能亢进症、甲状腺功能减退症、良性甲状腺肿或无甲状腺疾病[参照组])。
使用间隔censored 回归报告的几个自我报告的青春期里程碑的调整后平均年龄差异(月),以及使用 Huber-White 稳健方差估计的所有青春期里程碑的平均年龄差异(主要结果)。
患有甲状腺功能亢进症的母亲的儿子青春期发育较早(平均差异,-2.9[95%置信区间(CI),-5.0 至-0.7]个月),而未暴露于甲状腺功能亢进症的儿子则没有。母亲甲状腺功能减退症与儿子的青春期发育无关(平均差异,-1.2[95%CI,-5.1 至 2.7]个月)。我们观察到患有良性甲状腺肿的母亲的儿子青春期发育较早的非统计学意义的迹象(平均差异,-1.9[95%CI,-4.6 至 0.9]个月)。母亲的甲状腺疾病与女儿的青春期发育无关(平均差异(月),甲状腺功能亢进症,-0.8[95%CI,-2.8 至 1.2];甲状腺功能减退症,0.3[95%CI,-3.1 至 3.8];良性甲状腺肿,0.7[95%CI,-2.0 至 3.4])。
我们发现患有甲状腺功能亢进症的母亲的儿子青春期发育较早的迹象。需要进一步研究以进一步调查观察到的性别特异性关联。